Litcius/Paper detail

Lebrikizumab: First Approval

Susan J. Keam

2024Drugs21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtopic dermatitisDrug approvalPharmacotherapyFood and drug administrationPediatricsInternal medicineDermatologyPharmacologyDrugDermatology and Skin DiseasesAsthma and respiratory diseasesIL-33, ST2, and ILC Pathways
Lebrikizumab: First Approval | Litcius